High-precision microporous membranes and components designed to eliminate contamination and ensure critical patient safety.
Intravenous (IV) therapy is a cornerstone of modern clinical medicine, allowing for the rapid delivery of fluids, medications, and essential nutrition directly into a patient’s circulatory system. However, this direct pathway bypasses the body's natural defense barriers, such as the skin and gastrointestinal tract. Consequently, any contaminants present in the parenteral solution—including particulate matter, microbial pathogens, endotoxins, and air bubbles—pose an immediate and significant risk to the patient. This makes high-performance IV filters for parenteral solution purification indispensable components in clinical environments.
The global healthcare sector is witnessing a tightening of clinical guidelines and regulatory standards concerning infusion safety. Organizations such as the Infusion Nurses Society (INS), the U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) increasingly mandate or strongly recommend the use of inline IV filters for specific therapies. This regulatory push has accelerated the commercial demand for specialized filtration devices worldwide.
From an industrial perspective, manufacturers are challenged to produce membranes that offer not only absolute retention of micro-contaminants but also high flow rates, low protein binding (to prevent drug loss), and compatibility with aggressive solvents or lipid emulsions. The rising prevalence of complex oncology drugs, biologics, and multi-component Total Parenteral Nutrition (TPN) regimens has shifted the market focus toward multi-stage and material-optimized filtration solutions. Consequently, medical device developers are actively seeking partnerships with established membrane manufacturers capable of providing customized, regulatory-compliant filtration media.
Parenteral nutrition solutions are highly complex mixtures containing amino acids, glucose, vitamins, trace elements, and lipid emulsions. Standard 0.22-micron filters are unsuitable for lipid-containing infusions because the large fat droplets cannot pass through, leading to immediate clogging. Therefore, clinical guidelines dictate the use of 1.2-micron filters for lipid emulsions. These filters successfully trap large, unstable lipid aggregates, fungi (such as Candida albicans), and particulate matter while allowing the essential nutrients to pass safely into the patient's bloodstream.
Chemotherapy drugs are highly potent and often chemically aggressive. During preparation and administration, there is a risk of toxic aerosol generation. IV filters equipped with hydrophobic venting membranes allow air to escape while completely blocking the escape of hazardous liquid aerosols. Furthermore, the inline filtration membranes must be chemically compatible with various solvents and carriers used in oncology, ensuring that the filter housing and membrane do not degrade or leach substances during the infusion process.
Neonates and pediatric patients have extremely small blood vessels and highly sensitive physiological systems. Even minute amounts of particulate matter or air can have devastating consequences. The use of low-prime-volume inline IV filters is standard practice in NICUs to minimize the fluid volume contained within the tubing while providing reliable protection against micro-particles, bacteria, and air embolisms. Hydrophilic membranes with integrated hydrophobic vents are critical in these scenarios to ensure continuous, bubble-free fluid delivery.
In hemodialysis circuits, monitoring blood pressure is essential for patient safety. Transducer protectors (TP filters) act as a sterile barrier between the patient's bloodline and the dialysis machine's sensitive pressure sensors. Utilizing 0.22-micron hydrophobic PTFE membranes, these protectors allow air to pass freely for accurate pressure readings while preventing blood, dialysate, and airborne pathogens from contaminating the machine or cross-contaminating subsequent patients.
The performance of an IV filter is fundamentally determined by the characteristics of its microporous membrane. Different clinical applications require distinct polymer chemistries and surface modifications:
As medical technology advances, several key trends are shaping the future of IV filtration systems:
1. Smart and Integrated Filtration: Future IV sets will feature more compact, integrated designs where filters are seamlessly embedded into needle-free connectors, extension lines, or drip chambers. This reduces the weight of the tubing set and simplifies clinical setup, reducing the risk of tactile displacement or contamination.
2. Bio-compatible and Low-adsorption Materials: With the rise of highly sensitive biological drugs (such as monoclonal antibodies and gene therapies), there is a growing demand for membranes with near-zero protein and drug binding characteristics to ensure the patient receives the exact prescribed dose.
3. Advanced Endotoxin Retention: Development of membranes with enhanced positive surface charge (zeta potential) to achieve superior electrostatic adsorption of negatively charged endotoxins, even in high-flow clinical scenarios.
As a high-tech enterprise integrating research and development, production, and sales, we provide a wide assortment of membranes with different performance characteristics, making it easy for you to find the membrane that exactly fits your application. In addition, we have more than 30 years of extensive membrane manufacturing experience and deep expertise in related regulatory compliance. In cases where the available membranes or devices are not ideal for your application, our sales and R&D team will work closely with you to create tailor-made and reliable solutions to meet your specific application requirements.

Manufactured according to ISO standards, our wide assortment of membranes with different performance characteristics makes it easy for you to find the best membrane to fit your infusion applications. We combine extensive membrane manufacturing experience with advanced device engineering to create reliable, tailor-made solutions.

Our 0.22-micron hydrophobic membrane allows only sterile air to pass through, preventing blood and dialyzing fluid from damaging sensitive transducers. These Transducer Protector (TP) filters are widely used in hemodialysis bloodlines to protect both patients and equipment from cross-contamination.

Integrated with high-quality hydrophobic bacterial filter media to effectively prevent bacterium, moisture, and secretions from entering the line while maintaining laminar flow and excellent waveforms. Equipped with 0.22µm pore size PTFE membranes and medical-grade ABS housings.

Single-use transfer devices designed to make withdrawal and addition of medications easy and safe. Ideal for reconstituting and admixing drugs, enabling safe fluid transfer from vial to IV bag without waste. Vented models provide protection against toxic aerosols.
Explore our full range of high-performing, affordable filtration materials and devices designed for clinical professionals and medical device manufacturers.
Our technical and customer support teams always focus on the needs and satisfaction of our customers and are able and flexible to provide, optimize or develop products to solve your challenging filtration issues. It’s been our constant commitment to supporting our customers with products that meet both their budget and performance expectations, and to doing our part effectively to speed up the launch time of customer’s finished products to market.
Contact Our Filtration Experts